166 related articles for article (PubMed ID: 15149173)
1. Cross-linked microparticles as carriers for the delivery of plasmid DNA for vaccine development.
Goh SL; Murthy N; Xu M; Fréchet JM
Bioconjug Chem; 2004; 15(3):467-74. PubMed ID: 15149173
[TBL] [Abstract][Full Text] [Related]
2. Directed antigen presentation using polymeric microparticulate carriers degradable at lysosomal pH for controlled immune responses.
Kwon YJ; Standley SM; Goodwin AP; Gillies ER; Fréchet JM
Mol Pharm; 2005; 2(1):83-91. PubMed ID: 15804181
[TBL] [Abstract][Full Text] [Related]
3. Chemical adjuvants for plasmid DNA vaccines.
Greenland JR; Letvin NL
Vaccine; 2007 May; 25(19):3731-41. PubMed ID: 17350735
[TBL] [Abstract][Full Text] [Related]
4. Cationic microparticles are a potent delivery system for a HCV DNA vaccine.
O'Hagan DT; Singh M; Dong C; Ugozzoli M; Berger K; Glazer E; Selby M; Wininger M; Ng P; Crawford K; Paliard X; Coates S; Houghton M
Vaccine; 2004 Dec; 23(5):672-80. PubMed ID: 15542189
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles.
Pai Kasturi S; Qin H; Thomson KS; El-Bereir S; Cha SC; Neelapu S; Kwak LW; Roy K
J Control Release; 2006 Jul; 113(3):261-70. PubMed ID: 16793161
[TBL] [Abstract][Full Text] [Related]
6. Covalent conjugation of polyethyleneimine on biodegradable microparticles for delivery of plasmid DNA vaccines.
Kasturi SP; Sachaphibulkij K; Roy K
Biomaterials; 2005 Nov; 26(32):6375-85. PubMed ID: 15913771
[TBL] [Abstract][Full Text] [Related]
7. Cationic microparticles consisting of poly(lactide-co-glycolide) and polyethylenimine as carriers systems for parental DNA vaccination.
Oster CG; Kim N; Grode L; Barbu-Tudoran L; Schaper AK; Kaufmann SH; Kissel T
J Control Release; 2005 May; 104(2):359-77. PubMed ID: 15907586
[TBL] [Abstract][Full Text] [Related]
8. Fully acid-degradable biocompatible polyacetal microparticles for drug delivery.
Paramonov SE; Bachelder EM; Beaudette TT; Standley SM; Lee CC; Dashe J; Fréchet JM
Bioconjug Chem; 2008 Apr; 19(4):911-9. PubMed ID: 18373356
[TBL] [Abstract][Full Text] [Related]
9. Using TEM to couple transient protein distribution and release for PLGA microparticles for potential use as vaccine delivery vehicles.
Zhao A; Rodgers VG
J Control Release; 2006 Jun; 113(1):15-22. PubMed ID: 16707186
[TBL] [Abstract][Full Text] [Related]
10. Chitosan microparticles containing plasmid DNA as potential oral gene delivery system.
Guliyeva U; Oner F; Ozsoy S; Haziroğlu R
Eur J Pharm Biopharm; 2006 Jan; 62(1):17-25. PubMed ID: 16257520
[TBL] [Abstract][Full Text] [Related]
11. Novel biodegradable polymers as gene carriers.
Yang Y; Jia W; Qi X; Yang C; Liu L; Zhang Z; Ma J; Zhou S; Li X
Macromol Biosci; 2004 Dec; 4(12):1113-7. PubMed ID: 15586388
[TBL] [Abstract][Full Text] [Related]
12. Enhanced cell penetration of acid-degradable particles functionalized with cell-penetrating peptides.
Cohen JL; Almutairi A; Cohen JA; Bernstein M; Brody SL; Schuster DP; Fréchet JM
Bioconjug Chem; 2008 Apr; 19(4):876-81. PubMed ID: 18318462
[TBL] [Abstract][Full Text] [Related]
13. 'Smart' delivery systems for biomolecular therapeutics.
Stayton PS; El-Sayed ME; Murthy N; Bulmus V; Lackey C; Cheung C; Hoffman AS
Orthod Craniofac Res; 2005 Aug; 8(3):219-25. PubMed ID: 16022724
[TBL] [Abstract][Full Text] [Related]
14. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
Nilkumhang S; Basit AW
Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
[TBL] [Abstract][Full Text] [Related]
15. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
16. A biodegradable and biocompatible drug-delivery system based on polyoxalate microparticles.
Lee E; Kim S; Seong K; Park H; Seo H; Khang G; Lee D
J Biomater Sci Polym Ed; 2011; 22(13):1683-94. PubMed ID: 20699060
[TBL] [Abstract][Full Text] [Related]
17. Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.
Chong SY; Egan MA; Kutzler MA; Megati S; Masood A; Roopchard V; Garcia-Hand D; Montefiori DC; Quiroz J; Rosati M; Schadeck EB; Boyer JD; Pavlakis GN; Weiner DB; Sidhu M; Eldridge JH; Israel ZR
Vaccine; 2007 Jun; 25(26):4967-82. PubMed ID: 17335943
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis of polymeric drug nanomicrospheres containing probenecid].
Li QH; Wu ZC; Sun Y; Shen LJ
Guang Pu Xue Yu Guang Pu Fen Xi; 2004 Aug; 24(8):960-2. PubMed ID: 15766119
[TBL] [Abstract][Full Text] [Related]
19. Poly-L-lysine-coated nanoparticles: a potent delivery system to enhance DNA vaccine efficacy.
Minigo G; Scholzen A; Tang CK; Hanley JC; Kalkanidis M; Pietersz GA; Apostolopoulos V; Plebanski M
Vaccine; 2007 Jan; 25(7):1316-27. PubMed ID: 17052812
[TBL] [Abstract][Full Text] [Related]
20. Cellulose acetate butyrate-pH/thermosensitive polymer microcapsules containing aminated poly(vinyl alcohol) microspheres for oral administration of DNA.
Fundueanu G; Constantin M; Bortolotti F; Cortesi R; Ascenzi P; Menegatti E
Eur J Pharm Biopharm; 2007 Apr; 66(1):11-20. PubMed ID: 17085025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
